Switch to:
ChemoCentryx Inc (NAS:CCXI)
EV/EBITDA
-5.96 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, ChemoCentryx Inc's enterprise value is $262.98 Mil. ChemoCentryx Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $-44.10 Mil. Therefore, ChemoCentryx Inc's EV/EBITDA ratio for today is -5.96.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, ChemoCentryx Inc's stock price is $7.73. ChemoCentryx Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $-0.97. Therefore, ChemoCentryx Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

ChemoCentryx Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=262.982/-44.102
=-5.96

ChemoCentryx Inc's current Enterprise Value is $262.98 Mil.
ChemoCentryx Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was -11.558 (Dec. 2015 ) + -15.243 (Mar. 2016 ) + -10.057 (Jun. 2016 ) + -7.244 (Sep. 2016 ) = $-44.10 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

ChemoCentryx Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=7.73/-0.97
=

ChemoCentryx Inc's share price for today is $7.73.
ChemoCentryx Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was -0.26 (Dec. 2015 ) + -0.34 (Mar. 2016 ) + -0.22 (Jun. 2016 ) + -0.15 (Sep. 2016 ) = $-0.97.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

ChemoCentryx Inc Annual Data

Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 0.000.000.000.000.000.00-7.68-3.03-4.82-6.07

ChemoCentryx Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda -3.65-2.51-4.82-5.41-6.23-4.05-6.07-0.91-1.83-3.79
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK